Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARRIS - Another partner -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (281)	12/3/1997 9:37:00 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 353

Max: >>How's that for an opinion?<< Not so bad if we count on: >>..but I had been out of SQNA and ARRS and it is getting very tempting to jump back in at these levels.<< mz

To: Pseudo Biologist who wrote (281)	12/4/1997 8:51:00 AM
From: chirodoc	Respond to of 353

<<<<<Walker said fuller details about Delta were to be published soon in ''a major medical journal,'' whose name he said he was not yet allowed to disclose. ........i guess he is giving us a tip that good news is coming. notice that he said in the same article that he was uncertain why the stock sold off. ......i agree that the stock looks tempting at these levels .....everything i have read about walker is positive. i think i would bet on axys because of him + the combination companies strengths. ..but i still only have a very snall position--worried about my investment being dead money--not worried about downside--seems to be a bottom--problem is these bios can bottom for a year sometimes!